Strongyloidiasis risk factors: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (25 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Strongyloidiasis}} | {{Strongyloidiasis}} | ||
{{CMG}}; {{AE}} {{ADG}} | |||
==Overview== | ==Overview== | ||
Common risk factors in the development of strongyloidiasis include [[immunosuppressive therapies]] with [[corticosteroids]] and other medications, [[HTLV-1 infection]], [[organ transplantation]], [[immune reconstitution syndrome]], hematologic malignancies (especially [[lymphoma]]), [[tuberculosis]], and [[malnutrition]]. | |||
==Risk factors== | ==Risk factors== | ||
Common risk factors in the development of strongyloidiasis include:<ref name="pmid17042927">{{cite journal |vauthors=Evering T, Weiss LM |title=The immunology of parasite infections in immunocompromised hosts |journal=Parasite Immunol. |volume=28 |issue=11 |pages=549–65 |year=2006 |pmid=17042927 |pmc=3109637 |doi=10.1111/j.1365-3024.2006.00886.x |url=}}</ref><ref name="pmid26925367">{{cite journal |vauthors=Ostera G, Blum J |title=Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States |journal=Curr Trop Med Rep |volume=3 |issue= |pages=1–3 |year=2016 |pmid=26925367 |pmc=4757600 |doi=10.1007/s40475-016-0065-3 |url=}}</ref> | |||
*Occupations that increase contact with contaminated soil such as farming and coal mining | |||
*[[Human T-lymphotropic virus|Human T-cell lymphotropic virus]]-1 ([[HTLV-1|HTLV]]-1) infection | |||
*Occupations that increase contact with contaminated soil such as farming and coal mining | *[[Immunosuppressive therapy]] with [[corticosteroids]] and other medications, | ||
* | *[[Immune reconstitution syndrome]] | ||
*Hematologic malignancies ([[lymphoma]]) | |||
*[[Tuberculosis]] | |||
*[[Malnutrition]] | |||
*[[Diabetes mellitus]], [[chronic obstructive pulmonary disease]] ([[COPD]]), [[renal failure|chronic renal failure]]. | |||
*Living in endemic regions. | |||
*[[Alcoholism|Alcoholics]] | |||
*Travelers, immigrants | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Dermatology]] | |||
[[Category:Neurology]] | |||
[[Category:Pulmonology]] | |||
Latest revision as of 00:20, 30 July 2020
|
Strongyloidiasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Strongyloidiasis risk factors On the Web |
|
American Roentgen Ray Society Images of Strongyloidiasis risk factors |
|
Risk calculators and risk factors for Strongyloidiasis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of strongyloidiasis include immunosuppressive therapies with corticosteroids and other medications, HTLV-1 infection, organ transplantation, immune reconstitution syndrome, hematologic malignancies (especially lymphoma), tuberculosis, and malnutrition.
Risk factors
Common risk factors in the development of strongyloidiasis include:[1][2]
- Occupations that increase contact with contaminated soil such as farming and coal mining
- Human T-cell lymphotropic virus-1 (HTLV-1) infection
- Immunosuppressive therapy with corticosteroids and other medications,
- Immune reconstitution syndrome
- Hematologic malignancies (lymphoma)
- Tuberculosis
- Malnutrition
- Diabetes mellitus, chronic obstructive pulmonary disease (COPD), chronic renal failure.
- Living in endemic regions.
- Alcoholics
- Travelers, immigrants
References
- ↑ Evering T, Weiss LM (2006). "The immunology of parasite infections in immunocompromised hosts". Parasite Immunol. 28 (11): 549–65. doi:10.1111/j.1365-3024.2006.00886.x. PMC 3109637. PMID 17042927.
- ↑ Ostera G, Blum J (2016). "Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States". Curr Trop Med Rep. 3: 1–3. doi:10.1007/s40475-016-0065-3. PMC 4757600. PMID 26925367.